Back to Search Start Over

A molecular dynamics approach on the Y393C variant of protein disulfide isomerase A1.

Authors :
Madero-Ayala PA
Mares-Alejandre RE
Ramos-Ibarra MA
Source :
Chemical biology & drug design [Chem Biol Drug Des] 2020 Dec; Vol. 96 (6), pp. 1341-1347. Date of Electronic Publication: 2020 Jul 09.
Publication Year :
2020

Abstract

Human protein disulfide isomerase A1 (PDIA1) shows both catalytic (i.e., oxidoreductase) and non-catalytic (i.e., chaperone) activities and plays a crucial role in the oxidative folding of proteins within the endoplasmic reticulum. PDIA1 dysregulation is a common trait in numerous pathophysiological conditions, including neurodegenerative disorders and cancerous diseases. The 1178A>G mutation of the human PDIA1-encoding gene is a non-synonymous single nucleotide polymorphism detected in patients with Cole-Carpenter syndrome type 1 (CSS1), a particularly rare bone disease. In vitro studies showed that the encoded variant (PDIA1 Y393C) exhibits limited oxidoreductase activity. To gain knowledge on the structure-function relationship, we undertook a molecular dynamics (MD) approach to examine the structural stability of PDIA1 Y393C. Results showed that significant conformational changes are the structural consequence of the amino acid substitution Tyr>Cys at position 393 of the PDIA1 protein. This structure-based study provides further knowledge about the molecular origin of CCS1.<br /> (© 2020 John Wiley & Sons A/S.)

Details

Language :
English
ISSN :
1747-0285
Volume :
96
Issue :
6
Database :
MEDLINE
Journal :
Chemical biology & drug design
Publication Type :
Academic Journal
Accession number :
32352225
Full Text :
https://doi.org/10.1111/cbdd.13700